摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

贝那米星B | 116249-66-2

中文名称
贝那米星B
中文别名
——
英文名称
benanomicin B
英文别名
pradimicin C;(2R)-2-[[(5S,6S)-5-[(2S,3R,4S,5S,6R)-5-amino-3-hydroxy-6-methyl-4-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxy-1,6,9,14-tetrahydroxy-11-methoxy-3-methyl-8,13-dioxo-5,6-dihydrobenzo[a]tetracene-2-carbonyl]amino]propanoic acid
贝那米星B化学式
CAS
116249-66-2
化学式
C39H42N2O18
mdl
——
分子量
826.765
InChiKey
IHIIRQILYAXIOH-NUVDETJMSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 溶解度:
    可溶于DMSO

计算性质

  • 辛醇/水分配系数(LogP):
    -2.4
  • 重原子数:
    59
  • 可旋转键数:
    8
  • 环数:
    7.0
  • sp3杂化的碳原子比例:
    0.44
  • 拓扑面积:
    335
  • 氢给体数:
    11
  • 氢受体数:
    19

SDS

SDS:3b85b4ae2f7f8d0d359bc8d643851b4f
查看

反应信息

  • 作为反应物:
    描述:
    贝那米星B盐酸乙酸酐 作用下, 生成 methyl 4,6-dideoxy-4-amino-D-galactopyranoside
    参考文献:
    名称:
    The structure of pradimicins A, B and C: a novel family of antifungal antibiotics
    摘要:
    DOI:
    10.1021/jo00272a013
点击查看最新优质反应信息

文献信息

  • Antifungal activities of pradimicin derivatives modified at C4'-amino group.
    作者:HAJIME KAMACHI、SATSUKI OKUYAMA、MINORU HIRANO、SHINJI MASUYOSHI、MASATAKA KONISHI、TOSHIKAZU OKI
    DOI:10.7164/antibiotics.46.1246
    日期:——
    In order to explore potent derivatives of pradimicins (PRMs), modification of their C4'-amino group was carried out. 4'-N-Cyano (1, 2), 4'-deamino-4'-nitroguanidino (4), 4'-deamino-4'-ureido (7-9) and 4'-deamino-4'-thioureido (10) derivatives were synthesized by trimethylsilylation of PRMs A and C, followed by condensation with appropriate reagents. 4'-Deamino-4'-guanidino (5) and 4'-deamino-4'-amidino (6) derivatives were synthesized by catalytic hydrogenation of 4 and 2, respectively. 4'-N-Nitroso derivative 3 was prepared by treatment of PRM A with nitrous acid. Among these compounds, the 4'-N-cyano derivative of PRM C (2) exhibited in vitro and in vivo antifungal activities comparable to the parent compounds together with good water-solubility.
    为了探索普拉迪米星(PRMs)的强效衍生物,对其 C4'-基进行了修饰。通过对 PRMs A 和 C 进行三甲基硅烷化,然后用适当的试剂缩合,合成了 4'-N-Cyano (1, 2)、4'-deamino-4'-nitroguanidino (4)、4'-deamino-4'-ureido (7-9) 和 4'-deamino-4'-thioureido (10) 衍生物。4'-Deamino-4'-guanidino (5) 和 4'-deamino-4'-amidino (6) 衍生物分别由 4 和 2 催化加氢合成。4'-N-Nitroso 衍生物 3 是用亚硝酸处理 PRM A 而制备的。在这些化合物中,PRM C 的 4'-N-Cyano 衍生物(2)具有与母体化合物相当的体内外抗真菌活性和良好的溶性。
  • New antibiotic N-acetyl-benanomicin B, and the production and uses thereof
    申请人:ZAIDAN HOJIN BISEIBUTSU KAGAKU KENKYU KAI
    公开号:EP0378126A1
    公开(公告)日:1990-07-18
    As a new compound is now provided N-­acetylbenanomicin B which is useful as an antifungal agent and also as antiviral agent for inhibiting infec­tion of human T-cell with HIV, namely a virus causative of acquired human immunodeficiency syndrome. N-­acetylbenanomicin B may be prepared by acetylation of 4˝-amino group of benanomicin B which is fermentatively produced by a new microorganism, MH193-16F4 strain of actinomycetes.
    现在提供的一种新化合物 N-乙酰苯霉素 B 可用作抗真菌剂,也可用作抑制人类 T 细胞感染艾滋病毒(即导致获得性免疫缺陷综合征的病毒)的抗病毒剂。N-acetylbenanomicin B 可以通过乙酰化苯霉素 B 的 4˝-基来制备,苯霉素 B 是由放线菌 MH193-16F4 株这种新微生物发酵产生的。
  • Pradimicins L and FL and derivatives thereof
    申请人:BRISTOL-MYERS SQUIBB COMPANY
    公开号:EP0479505A1
    公开(公告)日:1992-04-08
    The present invention relates to novel antifungal antibiotics herein designated as pradimicin L and pradimicin FL, and derivatives thereof. Pradimicins L and FL are produced by Actinomadura verrucosospora subsp. neohibisca strain R103-3, ATCC No. 53930.
    本发明涉及新型抗真菌抗生素,在此命名为 Pradimicin L 和 Pradimicin FL 及其衍生物。Pradimicins L和FL由Actinomadura verrucospora subsp.neohibisca菌株R103-3(ATCC编号53930)产生。
  • Pradimic acids, amides, and novel pradimicin derivatives
    申请人:Bristol-Myers Squibb Company
    公开号:EP0580480A1
    公开(公告)日:1994-01-26
    The present invention relates to intermediates, pradimic acids and pradimic acid amides of the formula (II) wherein R is OH or NH₂; R¹ is hydrogen or a group of the formula with the proviso that when R is OH, R¹ is not hydrogen; Y is OH or NR²R³; R² is hydrogen or methyl; R³ is hydrogen, C₁₋₅ alkyl, or an amino protecting group; R⁴ is hydrogen, hydroxy protecting group, or β-D-xylosyl. The invention relates also to novel processes for the preparation of pradimic acids and pradimic acid amides, as well as novel pradimicin derivatives prepared therefrom.
    本发明涉及式 (II) 的中间体、普拉底米酸和普拉底米酸酰胺 其中 R 是 OH 或 NH₂;R¹是氢或式中的基团 但当 R 是 OH 时,R¹ 不是氢;Y 是 OH 或 NR²R³;R² 是氢或甲基;R³ 是氢、C₁₋₅ 烷基或基保护基;R⁴ 是氢、羟基保护基或β-D-木糖基。 本发明还涉及制备普拉底米酸和普拉底米酸酰胺的新型工艺,以及由此制备的新型普拉底米素衍生物
  • Pradimicin compounds
    申请人:Bristol-Myers Squibb Company
    公开号:EP0584014A1
    公开(公告)日:1994-02-23
    Disclosed are novel pradimicin compounds (I) which possess antifungal activity and, preferably, improved water solubility. The compounds of the invention are prepared by modifying the 4'-amino or 4'-alkylamino moieties of known pradimicin compounds. wherein R¹ is H, methyl, or hydroxymethyl, provided that when R¹ is methyl or hydroxymethyl, the resulting amino acid residue has the D configuration; R² is H or β-D-xylosyl; R³ is H or alkyl; R⁴ is -CN, -NO, or a pharmaceutically acceptable salt thereof.
    本发明公开了具有抗真菌活性的新型普拉提米星化合物 (I),最好还能提高其溶性。本发明的化合物是通过修饰已知的普拉迪明化合物的 4'- 基或 4'- 烷基基而制备的。 其中 R¹ 是 H、甲基或羟甲基,但当 R¹ 是甲基或羟甲基时,所得氨基酸残基具有 D 构型;R² 是 H 或 β-D-木糖基;R³ 是 H 或烷基;R⁴ 是 -CN、-NO、 或其药学上可接受的盐。
查看更多